Results 111 to 120 of about 4,152 (163)

Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus. [PDF]

ESMO Open
Aragon-Ching JB, Gupta S, Grivas P, Park SH, Petrylak DP, Sridhar SS, Gurney H, Jacob N, Tyroller K, Hoffman J, Bellmunt J.   +10 more
europepmc   +1 more source

Grivas, E

, 2016
Grivas, E
core  

Grivas, Nikos

, 2019
Grivas, Nikos
core  

Antioxidant effect of chromium picolinate on chronic exercise-induced oxidative stress in male rats. [PDF]

Sci Rep
Çibuk S, Sarikaya M, Ulema MS, Pancar Z, Öğe B, Embiyaoğlu NM, Aslan M, Aydemir İ, Keskin K, Yarayan YE, Grivas GV, Alkhamees NH, Sheeha BB, Al-Mhanna SB, Badicu G, Batrakoulis A.   +15 more
europepmc   +1 more source

Assessing the impact of ship emissions on the atmospheric chemical composition in the Eastern Mediterranean and the Piraeus port (Greece). [PDF]

Sci Rep
Poupkou A, Liora N, Kontos S, Grivas G, Fameli KM, Tsiaousidis D, Solomos S, Kapsomenakis I, Assimakopoulos V, Progiou A, Kalabokas P, Mihalopoulos N, Kotrikla AM, Melas D, Zerefos C.   +14 more
europepmc   +1 more source

Fanconi anemia complementation group C gene (FANCC) association with hereditary and sporadic renal tumors. [PDF]

Oncologist
Desai D, Sager RA, Basin M, Jacob JM, Morris GJ, Spiess PE, Li R, Cheng L, Necchi A, Kamat AM, Grivas P, Pavlick D, Goldberg H, Mollapour M, Lin D, Ross JS, Bratslavsky G, Basnet A, Daneshvar MA.   +18 more
europepmc   +1 more source

Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy. [PDF]

Oncologist
Mercinelli C, Pavlick D, Agarwal N, Spiess PE, Li R, Kamat AM, Grivas P, Gupta S, Maiorano BA, Tateo V, Cigliola A, Piacentini M, Jacob JM, Bratslavsky G, Basnet A, Ross JS, Necchi A.   +16 more
europepmc   +1 more source

PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving ¹⁷⁷Lu-PSMA-617. [PDF]

Radiology
Ghodsi A, Owens L, Demirci RA, Gafita A, Cheng HH, Hawley JE, Raychaudhuri R, Khan H, Sunkara R, Hsieh AC, Grivas P, Montgomery B, Yezefski TA, Nelson PS, Yu EY, Schweizer MT, Chen DL, Gulati R, Iravani A.   +18 more
europepmc   +1 more source

T:sapphire channel waveguide lasers produced by femtosecond and picosecond laser writing

Ultra-short pulse laser writing is a widely adopted method for rapid prototyping of channel waveguide lasers and amplifiers in the bulk of different types of transparent glasses, crystals and ceramic materials [1, 2].
Grivas, C., Corbari, C., Brambilla, G., Lagoudakis, P.G.   +3 more
core  

A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy. [PDF]

Future Oncol
Grivas P, Tagawa ST, Jain RK, Bupathi M, Balar A, Rezazadeh Kalebasty A, George S, Palmbos P, Nordquist L, Petrylak DP, Davis N, Sternberg CN, Agarwal N, Park C, Tonelli J, Zhou H, Bangs R, Loriot Y.   +17 more
europepmc   +1 more source